Association	O
of	O
COL4A3	B:C1332774
(	I:C1332774
rs55703767	I:C1332774
)	I:C1332774
,	O
MMP	O
-	I:C1334523
9	I:C1334523
(	I:C1334523
rs17576	I:C1334523
)	I:C1334523
and	O
TIMP	O
-	I:C1367459
1	I:C1367459
(	I:C1367459
rs6609533	I:C1367459
)	I:C1367459
gene	O
polymorphisms	O
with	O
susceptibility	O
to	O
type	O
2	I:C0011860
diabetes	I:C0011860
.	O

Association	O
of	O
COL4A3	O
(	I:C1332774
rs55703767	I:C1332774
)	I:C1332774
,	O
MMP	B:C1334523
-	I:C1334523
9	I:C1334523
(	I:C1334523
rs17576	I:C1334523
)	I:C1334523
and	O
TIMP	O
-	I:C1367459
1	I:C1367459
(	I:C1367459
rs6609533	I:C1367459
)	I:C1367459
gene	O
polymorphisms	O
with	O
susceptibility	O
to	O
type	O
2	I:C0011860
diabetes	I:C0011860
.	O

Association	O
of	O
COL4A3	O
(	I:C1332774
rs55703767	I:C1332774
)	I:C1332774
,	O
MMP	O
-	I:C1334523
9	I:C1334523
(	I:C1334523
rs17576	I:C1334523
)	I:C1334523
and	O
TIMP	B:C1367459
-	I:C1367459
1	I:C1367459
(	I:C1367459
rs6609533	I:C1367459
)	I:C1367459
gene	O
polymorphisms	O
with	O
susceptibility	O
to	O
type	O
2	I:C0011860
diabetes	I:C0011860
.	O

Association	O
of	O
COL4A3	O
(	I:C1332774
rs55703767	I:C1332774
)	I:C1332774
,	O
MMP	O
-	I:C1334523
9	I:C1334523
(	I:C1334523
rs17576	I:C1334523
)	I:C1334523
and	O
TIMP	O
-	I:C1367459
1	I:C1367459
(	I:C1367459
rs6609533	I:C1367459
)	I:C1367459
gene	O
polymorphisms	O
with	O
susceptibility	B:C0012655
to	O
type	O
2	I:C0011860
diabetes	I:C0011860
.	O

Association	O
of	O
COL4A3	O
(	I:C1332774
rs55703767	I:C1332774
)	I:C1332774
,	O
MMP	O
-	I:C1334523
9	I:C1334523
(	I:C1334523
rs17576	I:C1334523
)	I:C1334523
and	O
TIMP	O
-	I:C1367459
1	I:C1367459
(	I:C1367459
rs6609533	I:C1367459
)	I:C1367459
gene	O
polymorphisms	O
with	O
susceptibility	O
to	O
type	B:C0011860
2	I:C0011860
diabetes	I:C0011860
.	O

Type	B:C0011860
2	I:C0011860
diabetes	I:C0011860
(	O
Type	O
2	I:C0011860
diabetes	I:C0011860
)	O
is	O
defined	O
by	O
high	O
levels	O
of	I:C0428548
glucose	I:C0428548
in	O
the	O
blood	O
.	O

Type	O
2	I:C0011860
diabetes	I:C0011860
(	O
Type	B:C0011860
2	I:C0011860
diabetes	I:C0011860
)	O
is	O
defined	O
by	O
high	O
levels	O
of	I:C0428548
glucose	I:C0428548
in	O
the	O
blood	O
.	O

Type	O
2	I:C0011860
diabetes	I:C0011860
(	O
Type	O
2	I:C0011860
diabetes	I:C0011860
)	O
is	O
defined	O
by	O
high	O
levels	B:C0428548
of	I:C0428548
glucose	I:C0428548
in	O
the	O
blood	O
.	O

Type	O
2	I:C0011860
diabetes	I:C0011860
(	O
Type	O
2	I:C0011860
diabetes	I:C0011860
)	O
is	O
defined	O
by	O
high	O
levels	O
of	I:C0428548
glucose	I:C0428548
in	O
the	O
blood	B:C0005767
.	O

The	O
collagen	B:C0009333
IV	I:C0009333
level	O
is	O
associated	O
with	O
conditions	O
of	O
hyperglycemia	O
and	O
insulin	O
resistance	I:C0021655
.	O

The	O
collagen	O
IV	I:C0009333
level	O
is	O
associated	O
with	O
conditions	O
of	O
hyperglycemia	B:C0020456
and	O
insulin	O
resistance	I:C0021655
.	O

The	O
collagen	O
IV	I:C0009333
level	O
is	O
associated	O
with	O
conditions	O
of	O
hyperglycemia	O
and	O
insulin	B:C0021655
resistance	I:C0021655
.	O

Collagen	B:C1314894
type	I:C1314894
IV	I:C1314894
α3	I:C1314894
chain	I:C1314894
(	I:C1314894
COL4A3	I:C1314894
)	I:C1314894
is	O
a	O
structural	O
protein	I:C0582263
of	O
the	O
extracellular	O
matrix	I:C0015350
(	O
extracellular	O
matrix	I:C0015350
)	O
.	O

Collagen	O
type	I:C1314894
IV	I:C1314894
α3	I:C1314894
chain	I:C1314894
(	I:C1314894
COL4A3	I:C1314894
)	I:C1314894
is	O
a	O
structural	B:C0582263
protein	I:C0582263
of	O
the	O
extracellular	O
matrix	I:C0015350
(	O
extracellular	O
matrix	I:C0015350
)	O
.	O

Collagen	O
type	I:C1314894
IV	I:C1314894
α3	I:C1314894
chain	I:C1314894
(	I:C1314894
COL4A3	I:C1314894
)	I:C1314894
is	O
a	O
structural	O
protein	I:C0582263
of	O
the	O
extracellular	B:C0015350
matrix	I:C0015350
(	O
extracellular	O
matrix	I:C0015350
)	O
.	O

Collagen	O
type	I:C1314894
IV	I:C1314894
α3	I:C1314894
chain	I:C1314894
(	I:C1314894
COL4A3	I:C1314894
)	I:C1314894
is	O
a	O
structural	O
protein	I:C0582263
of	O
the	O
extracellular	O
matrix	I:C0015350
(	O
extracellular	B:C0015350
matrix	I:C0015350
)	O
.	O

Matrix	B:C0165519
metallopeptidase	I:C0165519
9	I:C0165519
(	O
Matrix	O
metallopeptidase	I:C0165519
9	I:C0165519
)	O
is	O
an	O
enzyme	O
that	O
degrades	O
the	O
extracellular	O
matrix	I:C0015350
and	O
its	O
activity	O
is	O
moderated	O
by	O
TIMP	O
metallopeptidase	I:C0145947
inhibitor	I:C0145947
1	I:C0145947
(	O
TIMP	O
metallopeptidase	I:C0145947
inhibitor	I:C0145947
1	I:C0145947
)	O
.	O

Matrix	O
metallopeptidase	I:C0165519
9	I:C0165519
(	O
Matrix	B:C0165519
metallopeptidase	I:C0165519
9	I:C0165519
)	O
is	O
an	O
enzyme	O
that	O
degrades	O
the	O
extracellular	O
matrix	I:C0015350
and	O
its	O
activity	O
is	O
moderated	O
by	O
TIMP	O
metallopeptidase	I:C0145947
inhibitor	I:C0145947
1	I:C0145947
(	O
TIMP	O
metallopeptidase	I:C0145947
inhibitor	I:C0145947
1	I:C0145947
)	O
.	O

Matrix	O
metallopeptidase	I:C0165519
9	I:C0165519
(	O
Matrix	O
metallopeptidase	I:C0165519
9	I:C0165519
)	O
is	O
an	O
enzyme	B:C0014442
that	O
degrades	O
the	O
extracellular	O
matrix	I:C0015350
and	O
its	O
activity	O
is	O
moderated	O
by	O
TIMP	O
metallopeptidase	I:C0145947
inhibitor	I:C0145947
1	I:C0145947
(	O
TIMP	O
metallopeptidase	I:C0145947
inhibitor	I:C0145947
1	I:C0145947
)	O
.	O

Matrix	O
metallopeptidase	I:C0165519
9	I:C0165519
(	O
Matrix	O
metallopeptidase	I:C0165519
9	I:C0165519
)	O
is	O
an	O
enzyme	O
that	O
degrades	O
the	O
extracellular	B:C0015350
matrix	I:C0015350
and	O
its	O
activity	O
is	O
moderated	O
by	O
TIMP	O
metallopeptidase	I:C0145947
inhibitor	I:C0145947
1	I:C0145947
(	O
TIMP	O
metallopeptidase	I:C0145947
inhibitor	I:C0145947
1	I:C0145947
)	O
.	O

Matrix	O
metallopeptidase	I:C0165519
9	I:C0165519
(	O
Matrix	O
metallopeptidase	I:C0165519
9	I:C0165519
)	O
is	O
an	O
enzyme	O
that	O
degrades	O
the	O
extracellular	O
matrix	I:C0015350
and	O
its	O
activity	B:C0243102
is	O
moderated	O
by	O
TIMP	O
metallopeptidase	I:C0145947
inhibitor	I:C0145947
1	I:C0145947
(	O
TIMP	O
metallopeptidase	I:C0145947
inhibitor	I:C0145947
1	I:C0145947
)	O
.	O

Matrix	O
metallopeptidase	I:C0165519
9	I:C0165519
(	O
Matrix	O
metallopeptidase	I:C0165519
9	I:C0165519
)	O
is	O
an	O
enzyme	O
that	O
degrades	O
the	O
extracellular	O
matrix	I:C0015350
and	O
its	O
activity	O
is	O
moderated	O
by	O
TIMP	B:C0145947
metallopeptidase	I:C0145947
inhibitor	I:C0145947
1	I:C0145947
(	O
TIMP	O
metallopeptidase	I:C0145947
inhibitor	I:C0145947
1	I:C0145947
)	O
.	O

Matrix	O
metallopeptidase	I:C0165519
9	I:C0165519
(	O
Matrix	O
metallopeptidase	I:C0165519
9	I:C0165519
)	O
is	O
an	O
enzyme	O
that	O
degrades	O
the	O
extracellular	O
matrix	I:C0015350
and	O
its	O
activity	O
is	O
moderated	O
by	O
TIMP	O
metallopeptidase	I:C0145947
inhibitor	I:C0145947
1	I:C0145947
(	O
TIMP	B:C0145947
metallopeptidase	I:C0145947
inhibitor	I:C0145947
1	I:C0145947
)	O
.	O

The	O
aim	O
of	O
the	O
current	O
study	O
was	O
to	O
examine	O
the	O
association	O
between	O
genetic	B:C0032529
polymorphisms	I:C0032529
of	O
COL4A3	O
(	I:C1332774
rs55703767	I:C1332774
)	I:C1332774
,	O
MMP	O
-	I:C1334523
9	I:C1334523
(	I:C1334523
rs17576	I:C1334523
)	I:C1334523
and	O
TIMP	O
-	I:C1367459
1	I:C1367459
(	I:C1367459
rs6609533	I:C1367459
)	I:C1367459
in	O
patients	O
with	O
Type	O
2	I:C0011860
diabetes	I:C0011860
.	O

The	O
aim	O
of	O
the	O
current	O
study	O
was	O
to	O
examine	O
the	O
association	O
between	O
genetic	O
polymorphisms	I:C0032529
of	O
COL4A3	B:C1332774
(	I:C1332774
rs55703767	I:C1332774
)	I:C1332774
,	O
MMP	O
-	I:C1334523
9	I:C1334523
(	I:C1334523
rs17576	I:C1334523
)	I:C1334523
and	O
TIMP	O
-	I:C1367459
1	I:C1367459
(	I:C1367459
rs6609533	I:C1367459
)	I:C1367459
in	O
patients	O
with	O
Type	O
2	I:C0011860
diabetes	I:C0011860
.	O

The	O
aim	O
of	O
the	O
current	O
study	O
was	O
to	O
examine	O
the	O
association	O
between	O
genetic	O
polymorphisms	I:C0032529
of	O
COL4A3	O
(	I:C1332774
rs55703767	I:C1332774
)	I:C1332774
,	O
MMP	B:C1334523
-	I:C1334523
9	I:C1334523
(	I:C1334523
rs17576	I:C1334523
)	I:C1334523
and	O
TIMP	O
-	I:C1367459
1	I:C1367459
(	I:C1367459
rs6609533	I:C1367459
)	I:C1367459
in	O
patients	O
with	O
Type	O
2	I:C0011860
diabetes	I:C0011860
.	O

The	O
aim	O
of	O
the	O
current	O
study	O
was	O
to	O
examine	O
the	O
association	O
between	O
genetic	O
polymorphisms	I:C0032529
of	O
COL4A3	O
(	I:C1332774
rs55703767	I:C1332774
)	I:C1332774
,	O
MMP	O
-	I:C1334523
9	I:C1334523
(	I:C1334523
rs17576	I:C1334523
)	I:C1334523
and	O
TIMP	B:C1367459
-	I:C1367459
1	I:C1367459
(	I:C1367459
rs6609533	I:C1367459
)	I:C1367459
in	O
patients	O
with	O
Type	O
2	I:C0011860
diabetes	I:C0011860
.	O

The	O
aim	O
of	O
the	O
current	O
study	O
was	O
to	O
examine	O
the	O
association	O
between	O
genetic	O
polymorphisms	I:C0032529
of	O
COL4A3	O
(	I:C1332774
rs55703767	I:C1332774
)	I:C1332774
,	O
MMP	O
-	I:C1334523
9	I:C1334523
(	I:C1334523
rs17576	I:C1334523
)	I:C1334523
and	O
TIMP	O
-	I:C1367459
1	I:C1367459
(	I:C1367459
rs6609533	I:C1367459
)	I:C1367459
in	O
patients	O
with	O
Type	B:C0011860
2	I:C0011860
diabetes	I:C0011860
.	O

This	O
case	B:C0007328
-	I:C0007328
control	I:C0007328
study	I:C0007328
was	O
performed	O
on	O
120	O
Iranian	O
patients	O
with	O
Type	O
2	I:C0011860
diabetes	I:C0011860
and	O
120	O
healthy	O
individuals	I:C0237401
.	O

This	O
case	O
-	I:C0007328
control	I:C0007328
study	I:C0007328
was	O
performed	O
on	O
120	O
Iranian	B:C1553355
patients	O
with	O
Type	O
2	I:C0011860
diabetes	I:C0011860
and	O
120	O
healthy	O
individuals	I:C0237401
.	O

This	O
case	O
-	I:C0007328
control	I:C0007328
study	I:C0007328
was	O
performed	O
on	O
120	O
Iranian	O
patients	O
with	O
Type	B:C0011860
2	I:C0011860
diabetes	I:C0011860
and	O
120	O
healthy	O
individuals	I:C0237401
.	O

This	O
case	O
-	I:C0007328
control	I:C0007328
study	I:C0007328
was	O
performed	O
on	O
120	O
Iranian	O
patients	O
with	O
Type	O
2	I:C0011860
diabetes	I:C0011860
and	O
120	O
healthy	B:C0237401
individuals	I:C0237401
.	O

Genotypes	O
were	O
analyzed	B:C2732542
using	I:C2732542
the	I:C2732542
amplification	I:C2732542
refractory	I:C2732542
mutation	I:C2732542
system	I:C2732542
-	I:C2732542
polymerase	I:C2732542
chain	I:C2732542
reaction	I:C2732542
technique	I:C2732542
.	O

The	O
findings	O
demonstrated	O
significant	O
differences	O
between	O
genotypic	O
and	O
allelic	B:C0002085
distributions	O
of	O
COL4A3	O
(	O
G	O
/	O
T	O
)	O
and	O
Matrix	O
metallopeptidase	I:C1334523
9	I:C1334523
(	O
A	O
/	O
G	O
)	O
polymorphisms	O
as	O
follows	O
:	O
COL4A3	O
(	O
G	O
/	O
T	O
)	O
;	O
TT	O
vs.	O
GG	O
,	O
odds	O
ratio	O
(	O
OR	O
)	O
=0.235	O
,	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
)	O
=0.063-0.0802	O
(	O
P=0.013	O
)	O
and	O
T	O
vs.	O
G	O
,	O
OR	O
=0.592	O
,	O
95	O
%	O
CI	O
=0.371-0.943	O
(	O
P=0.026	O
)	O
;	O
Matrix	O
metallopeptidase	I:C1334523
9	I:C1334523
(	O
A	O
/	O
G	O
)	O
;	O
A	O
G	O
vs.	O
GG	O
,	O
OR	O
=	O
2.429	O
,	O
95	O
%	O
CI	O
=	O
1.232-4.820	O
(	O
P=0.008	O
)	O
and	O
A	O
vs.	O
G	O
,	O
OR	O
=	O
2.176	O
,	O
95	O
%	O
CI	O
=	O
1.155-4.130	O
(	O
P=0.013	O
)	O
.	O

The	O
findings	O
demonstrated	O
significant	O
differences	O
between	O
genotypic	O
and	O
allelic	O
distributions	O
of	O
COL4A3	B:C1332774
(	O
G	O
/	O
T	O
)	O
and	O
Matrix	O
metallopeptidase	I:C1334523
9	I:C1334523
(	O
A	O
/	O
G	O
)	O
polymorphisms	O
as	O
follows	O
:	O
COL4A3	O
(	O
G	O
/	O
T	O
)	O
;	O
TT	O
vs.	O
GG	O
,	O
odds	O
ratio	O
(	O
OR	O
)	O
=0.235	O
,	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
)	O
=0.063-0.0802	O
(	O
P=0.013	O
)	O
and	O
T	O
vs.	O
G	O
,	O
OR	O
=0.592	O
,	O
95	O
%	O
CI	O
=0.371-0.943	O
(	O
P=0.026	O
)	O
;	O
Matrix	O
metallopeptidase	I:C1334523
9	I:C1334523
(	O
A	O
/	O
G	O
)	O
;	O
A	O
G	O
vs.	O
GG	O
,	O
OR	O
=	O
2.429	O
,	O
95	O
%	O
CI	O
=	O
1.232-4.820	O
(	O
P=0.008	O
)	O
and	O
A	O
vs.	O
G	O
,	O
OR	O
=	O
2.176	O
,	O
95	O
%	O
CI	O
=	O
1.155-4.130	O
(	O
P=0.013	O
)	O
.	O

The	O
findings	O
demonstrated	O
significant	O
differences	O
between	O
genotypic	O
and	O
allelic	O
distributions	O
of	O
COL4A3	O
(	O
G	B:C0018321
/	O
T	O
)	O
and	O
Matrix	O
metallopeptidase	I:C1334523
9	I:C1334523
(	O
A	O
/	O
G	O
)	O
polymorphisms	O
as	O
follows	O
:	O
COL4A3	O
(	O
G	O
/	O
T	O
)	O
;	O
TT	O
vs.	O
GG	O
,	O
odds	O
ratio	O
(	O
OR	O
)	O
=0.235	O
,	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
)	O
=0.063-0.0802	O
(	O
P=0.013	O
)	O
and	O
T	O
vs.	O
G	O
,	O
OR	O
=0.592	O
,	O
95	O
%	O
CI	O
=0.371-0.943	O
(	O
P=0.026	O
)	O
;	O
Matrix	O
metallopeptidase	I:C1334523
9	I:C1334523
(	O
A	O
/	O
G	O
)	O
;	O
A	O
G	O
vs.	O
GG	O
,	O
OR	O
=	O
2.429	O
,	O
95	O
%	O
CI	O
=	O
1.232-4.820	O
(	O
P=0.008	O
)	O
and	O
A	O
vs.	O
G	O
,	O
OR	O
=	O
2.176	O
,	O
95	O
%	O
CI	O
=	O
1.155-4.130	O
(	O
P=0.013	O
)	O
.	O

The	O
findings	O
demonstrated	O
significant	O
differences	O
between	O
genotypic	O
and	O
allelic	O
distributions	O
of	O
COL4A3	O
(	O
G	O
/	O
T	B:C0040087
)	O
and	O
Matrix	O
metallopeptidase	I:C1334523
9	I:C1334523
(	O
A	O
/	O
G	O
)	O
polymorphisms	O
as	O
follows	O
:	O
COL4A3	O
(	O
G	O
/	O
T	O
)	O
;	O
TT	O
vs.	O
GG	O
,	O
odds	O
ratio	O
(	O
OR	O
)	O
=0.235	O
,	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
)	O
=0.063-0.0802	O
(	O
P=0.013	O
)	O
and	O
T	O
vs.	O
G	O
,	O
OR	O
=0.592	O
,	O
95	O
%	O
CI	O
=0.371-0.943	O
(	O
P=0.026	O
)	O
;	O
Matrix	O
metallopeptidase	I:C1334523
9	I:C1334523
(	O
A	O
/	O
G	O
)	O
;	O
A	O
G	O
vs.	O
GG	O
,	O
OR	O
=	O
2.429	O
,	O
95	O
%	O
CI	O
=	O
1.232-4.820	O
(	O
P=0.008	O
)	O
and	O
A	O
vs.	O
G	O
,	O
OR	O
=	O
2.176	O
,	O
95	O
%	O
CI	O
=	O
1.155-4.130	O
(	O
P=0.013	O
)	O
.	O

The	O
findings	O
demonstrated	O
significant	O
differences	O
between	O
genotypic	O
and	O
allelic	O
distributions	O
of	O
COL4A3	O
(	O
G	O
/	O
T	O
)	O
and	O
Matrix	B:C1334523
metallopeptidase	I:C1334523
9	I:C1334523
(	O
A	O
/	O
G	O
)	O
polymorphisms	O
as	O
follows	O
:	O
COL4A3	O
(	O
G	O
/	O
T	O
)	O
;	O
TT	O
vs.	O
GG	O
,	O
odds	O
ratio	O
(	O
OR	O
)	O
=0.235	O
,	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
)	O
=0.063-0.0802	O
(	O
P=0.013	O
)	O
and	O
T	O
vs.	O
G	O
,	O
OR	O
=0.592	O
,	O
95	O
%	O
CI	O
=0.371-0.943	O
(	O
P=0.026	O
)	O
;	O
Matrix	O
metallopeptidase	I:C1334523
9	I:C1334523
(	O
A	O
/	O
G	O
)	O
;	O
A	O
G	O
vs.	O
GG	O
,	O
OR	O
=	O
2.429	O
,	O
95	O
%	O
CI	O
=	O
1.232-4.820	O
(	O
P=0.008	O
)	O
and	O
A	O
vs.	O
G	O
,	O
OR	O
=	O
2.176	O
,	O
95	O
%	O
CI	O
=	O
1.155-4.130	O
(	O
P=0.013	O
)	O
.	O

The	O
findings	O
demonstrated	O
significant	O
differences	O
between	O
genotypic	O
and	O
allelic	O
distributions	O
of	O
COL4A3	O
(	O
G	O
/	O
T	O
)	O
and	O
Matrix	O
metallopeptidase	I:C1334523
9	I:C1334523
(	O
A	B:C0001407
/	O
G	O
)	O
polymorphisms	O
as	O
follows	O
:	O
COL4A3	O
(	O
G	O
/	O
T	O
)	O
;	O
TT	O
vs.	O
GG	O
,	O
odds	O
ratio	O
(	O
OR	O
)	O
=0.235	O
,	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
)	O
=0.063-0.0802	O
(	O
P=0.013	O
)	O
and	O
T	O
vs.	O
G	O
,	O
OR	O
=0.592	O
,	O
95	O
%	O
CI	O
=0.371-0.943	O
(	O
P=0.026	O
)	O
;	O
Matrix	O
metallopeptidase	I:C1334523
9	I:C1334523
(	O
A	O
/	O
G	O
)	O
;	O
A	O
G	O
vs.	O
GG	O
,	O
OR	O
=	O
2.429	O
,	O
95	O
%	O
CI	O
=	O
1.232-4.820	O
(	O
P=0.008	O
)	O
and	O
A	O
vs.	O
G	O
,	O
OR	O
=	O
2.176	O
,	O
95	O
%	O
CI	O
=	O
1.155-4.130	O
(	O
P=0.013	O
)	O
.	O

The	O
findings	O
demonstrated	O
significant	O
differences	O
between	O
genotypic	O
and	O
allelic	O
distributions	O
of	O
COL4A3	O
(	O
G	O
/	O
T	O
)	O
and	O
Matrix	O
metallopeptidase	I:C1334523
9	I:C1334523
(	O
A	O
/	O
G	B:C0018321
)	O
polymorphisms	O
as	O
follows	O
:	O
COL4A3	O
(	O
G	O
/	O
T	O
)	O
;	O
TT	O
vs.	O
GG	O
,	O
odds	O
ratio	O
(	O
OR	O
)	O
=0.235	O
,	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
)	O
=0.063-0.0802	O
(	O
P=0.013	O
)	O
and	O
T	O
vs.	O
G	O
,	O
OR	O
=0.592	O
,	O
95	O
%	O
CI	O
=0.371-0.943	O
(	O
P=0.026	O
)	O
;	O
Matrix	O
metallopeptidase	I:C1334523
9	I:C1334523
(	O
A	O
/	O
G	O
)	O
;	O
A	O
G	O
vs.	O
GG	O
,	O
OR	O
=	O
2.429	O
,	O
95	O
%	O
CI	O
=	O
1.232-4.820	O
(	O
P=0.008	O
)	O
and	O
A	O
vs.	O
G	O
,	O
OR	O
=	O
2.176	O
,	O
95	O
%	O
CI	O
=	O
1.155-4.130	O
(	O
P=0.013	O
)	O
.	O

The	O
findings	O
demonstrated	O
significant	O
differences	O
between	O
genotypic	O
and	O
allelic	O
distributions	O
of	O
COL4A3	O
(	O
G	O
/	O
T	O
)	O
and	O
Matrix	O
metallopeptidase	I:C1334523
9	I:C1334523
(	O
A	O
/	O
G	O
)	O
polymorphisms	O
as	O
follows	O
:	O
COL4A3	B:C1332774
(	O
G	O
/	O
T	O
)	O
;	O
TT	O
vs.	O
GG	O
,	O
odds	O
ratio	O
(	O
OR	O
)	O
=0.235	O
,	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
)	O
=0.063-0.0802	O
(	O
P=0.013	O
)	O
and	O
T	O
vs.	O
G	O
,	O
OR	O
=0.592	O
,	O
95	O
%	O
CI	O
=0.371-0.943	O
(	O
P=0.026	O
)	O
;	O
Matrix	O
metallopeptidase	I:C1334523
9	I:C1334523
(	O
A	O
/	O
G	O
)	O
;	O
A	O
G	O
vs.	O
GG	O
,	O
OR	O
=	O
2.429	O
,	O
95	O
%	O
CI	O
=	O
1.232-4.820	O
(	O
P=0.008	O
)	O
and	O
A	O
vs.	O
G	O
,	O
OR	O
=	O
2.176	O
,	O
95	O
%	O
CI	O
=	O
1.155-4.130	O
(	O
P=0.013	O
)	O
.	O

The	O
findings	O
demonstrated	O
significant	O
differences	O
between	O
genotypic	O
and	O
allelic	O
distributions	O
of	O
COL4A3	O
(	O
G	O
/	O
T	O
)	O
and	O
Matrix	O
metallopeptidase	I:C1334523
9	I:C1334523
(	O
A	O
/	O
G	O
)	O
polymorphisms	O
as	O
follows	O
:	O
COL4A3	O
(	O
G	B:C0018321
/	O
T	O
)	O
;	O
TT	O
vs.	O
GG	O
,	O
odds	O
ratio	O
(	O
OR	O
)	O
=0.235	O
,	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
)	O
=0.063-0.0802	O
(	O
P=0.013	O
)	O
and	O
T	O
vs.	O
G	O
,	O
OR	O
=0.592	O
,	O
95	O
%	O
CI	O
=0.371-0.943	O
(	O
P=0.026	O
)	O
;	O
Matrix	O
metallopeptidase	I:C1334523
9	I:C1334523
(	O
A	O
/	O
G	O
)	O
;	O
A	O
G	O
vs.	O
GG	O
,	O
OR	O
=	O
2.429	O
,	O
95	O
%	O
CI	O
=	O
1.232-4.820	O
(	O
P=0.008	O
)	O
and	O
A	O
vs.	O
G	O
,	O
OR	O
=	O
2.176	O
,	O
95	O
%	O
CI	O
=	O
1.155-4.130	O
(	O
P=0.013	O
)	O
.	O

The	O
findings	O
demonstrated	O
significant	O
differences	O
between	O
genotypic	O
and	O
allelic	O
distributions	O
of	O
COL4A3	O
(	O
G	O
/	O
T	O
)	O
and	O
Matrix	O
metallopeptidase	I:C1334523
9	I:C1334523
(	O
A	O
/	O
G	O
)	O
polymorphisms	O
as	O
follows	O
:	O
COL4A3	O
(	O
G	O
/	O
T	B:C0040087
)	O
;	O
TT	O
vs.	O
GG	O
,	O
odds	O
ratio	O
(	O
OR	O
)	O
=0.235	O
,	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
)	O
=0.063-0.0802	O
(	O
P=0.013	O
)	O
and	O
T	O
vs.	O
G	O
,	O
OR	O
=0.592	O
,	O
95	O
%	O
CI	O
=0.371-0.943	O
(	O
P=0.026	O
)	O
;	O
Matrix	O
metallopeptidase	I:C1334523
9	I:C1334523
(	O
A	O
/	O
G	O
)	O
;	O
A	O
G	O
vs.	O
GG	O
,	O
OR	O
=	O
2.429	O
,	O
95	O
%	O
CI	O
=	O
1.232-4.820	O
(	O
P=0.008	O
)	O
and	O
A	O
vs.	O
G	O
,	O
OR	O
=	O
2.176	O
,	O
95	O
%	O
CI	O
=	O
1.155-4.130	O
(	O
P=0.013	O
)	O
.	O

The	O
findings	O
demonstrated	O
significant	O
differences	O
between	O
genotypic	O
and	O
allelic	O
distributions	O
of	O
COL4A3	O
(	O
G	O
/	O
T	O
)	O
and	O
Matrix	O
metallopeptidase	I:C1334523
9	I:C1334523
(	O
A	O
/	O
G	O
)	O
polymorphisms	O
as	O
follows	O
:	O
COL4A3	O
(	O
G	O
/	O
T	O
)	O
;	O
TT	B:C0040087
vs.	O
GG	O
,	O
odds	O
ratio	O
(	O
OR	O
)	O
=0.235	O
,	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
)	O
=0.063-0.0802	O
(	O
P=0.013	O
)	O
and	O
T	O
vs.	O
G	O
,	O
OR	O
=0.592	O
,	O
95	O
%	O
CI	O
=0.371-0.943	O
(	O
P=0.026	O
)	O
;	O
Matrix	O
metallopeptidase	I:C1334523
9	I:C1334523
(	O
A	O
/	O
G	O
)	O
;	O
A	O
G	O
vs.	O
GG	O
,	O
OR	O
=	O
2.429	O
,	O
95	O
%	O
CI	O
=	O
1.232-4.820	O
(	O
P=0.008	O
)	O
and	O
A	O
vs.	O
G	O
,	O
OR	O
=	O
2.176	O
,	O
95	O
%	O
CI	O
=	O
1.155-4.130	O
(	O
P=0.013	O
)	O
.	O

The	O
findings	O
demonstrated	O
significant	O
differences	O
between	O
genotypic	O
and	O
allelic	O
distributions	O
of	O
COL4A3	O
(	O
G	O
/	O
T	O
)	O
and	O
Matrix	O
metallopeptidase	I:C1334523
9	I:C1334523
(	O
A	O
/	O
G	O
)	O
polymorphisms	O
as	O
follows	O
:	O
COL4A3	O
(	O
G	O
/	O
T	O
)	O
;	O
TT	O
vs.	O
GG	B:C0018321
,	O
odds	O
ratio	O
(	O
OR	O
)	O
=0.235	O
,	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
)	O
=0.063-0.0802	O
(	O
P=0.013	O
)	O
and	O
T	O
vs.	O
G	O
,	O
OR	O
=0.592	O
,	O
95	O
%	O
CI	O
=0.371-0.943	O
(	O
P=0.026	O
)	O
;	O
Matrix	O
metallopeptidase	I:C1334523
9	I:C1334523
(	O
A	O
/	O
G	O
)	O
;	O
A	O
G	O
vs.	O
GG	O
,	O
OR	O
=	O
2.429	O
,	O
95	O
%	O
CI	O
=	O
1.232-4.820	O
(	O
P=0.008	O
)	O
and	O
A	O
vs.	O
G	O
,	O
OR	O
=	O
2.176	O
,	O
95	O
%	O
CI	O
=	O
1.155-4.130	O
(	O
P=0.013	O
)	O
.	O

The	O
findings	O
demonstrated	O
significant	O
differences	O
between	O
genotypic	O
and	O
allelic	O
distributions	O
of	O
COL4A3	O
(	O
G	O
/	O
T	O
)	O
and	O
Matrix	O
metallopeptidase	I:C1334523
9	I:C1334523
(	O
A	O
/	O
G	O
)	O
polymorphisms	O
as	O
follows	O
:	O
COL4A3	O
(	O
G	O
/	O
T	O
)	O
;	O
TT	O
vs.	O
GG	O
,	O
odds	O
ratio	O
(	O
OR	O
)	O
=0.235	O
,	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
)	O
=0.063-0.0802	O
(	O
P=0.013	O
)	O
and	O
T	B:C0040087
vs.	O
G	O
,	O
OR	O
=0.592	O
,	O
95	O
%	O
CI	O
=0.371-0.943	O
(	O
P=0.026	O
)	O
;	O
Matrix	O
metallopeptidase	I:C1334523
9	I:C1334523
(	O
A	O
/	O
G	O
)	O
;	O
A	O
G	O
vs.	O
GG	O
,	O
OR	O
=	O
2.429	O
,	O
95	O
%	O
CI	O
=	O
1.232-4.820	O
(	O
P=0.008	O
)	O
and	O
A	O
vs.	O
G	O
,	O
OR	O
=	O
2.176	O
,	O
95	O
%	O
CI	O
=	O
1.155-4.130	O
(	O
P=0.013	O
)	O
.	O

The	O
findings	O
demonstrated	O
significant	O
differences	O
between	O
genotypic	O
and	O
allelic	O
distributions	O
of	O
COL4A3	O
(	O
G	O
/	O
T	O
)	O
and	O
Matrix	O
metallopeptidase	I:C1334523
9	I:C1334523
(	O
A	O
/	O
G	O
)	O
polymorphisms	O
as	O
follows	O
:	O
COL4A3	O
(	O
G	O
/	O
T	O
)	O
;	O
TT	O
vs.	O
GG	O
,	O
odds	O
ratio	O
(	O
OR	O
)	O
=0.235	O
,	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
)	O
=0.063-0.0802	O
(	O
P=0.013	O
)	O
and	O
T	O
vs.	O
G	B:C0018321
,	O
OR	O
=0.592	O
,	O
95	O
%	O
CI	O
=0.371-0.943	O
(	O
P=0.026	O
)	O
;	O
Matrix	O
metallopeptidase	I:C1334523
9	I:C1334523
(	O
A	O
/	O
G	O
)	O
;	O
A	O
G	O
vs.	O
GG	O
,	O
OR	O
=	O
2.429	O
,	O
95	O
%	O
CI	O
=	O
1.232-4.820	O
(	O
P=0.008	O
)	O
and	O
A	O
vs.	O
G	O
,	O
OR	O
=	O
2.176	O
,	O
95	O
%	O
CI	O
=	O
1.155-4.130	O
(	O
P=0.013	O
)	O
.	O

The	O
findings	O
demonstrated	O
significant	O
differences	O
between	O
genotypic	O
and	O
allelic	O
distributions	O
of	O
COL4A3	O
(	O
G	O
/	O
T	O
)	O
and	O
Matrix	O
metallopeptidase	I:C1334523
9	I:C1334523
(	O
A	O
/	O
G	O
)	O
polymorphisms	O
as	O
follows	O
:	O
COL4A3	O
(	O
G	O
/	O
T	O
)	O
;	O
TT	O
vs.	O
GG	O
,	O
odds	O
ratio	O
(	O
OR	O
)	O
=0.235	O
,	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
)	O
=0.063-0.0802	O
(	O
P=0.013	O
)	O
and	O
T	O
vs.	O
G	O
,	O
OR	O
=0.592	O
,	O
95	O
%	O
CI	O
=0.371-0.943	O
(	O
P=0.026	O
)	O
;	O
Matrix	B:C1334523
metallopeptidase	I:C1334523
9	I:C1334523
(	O
A	O
/	O
G	O
)	O
;	O
A	O
G	O
vs.	O
GG	O
,	O
OR	O
=	O
2.429	O
,	O
95	O
%	O
CI	O
=	O
1.232-4.820	O
(	O
P=0.008	O
)	O
and	O
A	O
vs.	O
G	O
,	O
OR	O
=	O
2.176	O
,	O
95	O
%	O
CI	O
=	O
1.155-4.130	O
(	O
P=0.013	O
)	O
.	O

The	O
findings	O
demonstrated	O
significant	O
differences	O
between	O
genotypic	O
and	O
allelic	O
distributions	O
of	O
COL4A3	O
(	O
G	O
/	O
T	O
)	O
and	O
Matrix	O
metallopeptidase	I:C1334523
9	I:C1334523
(	O
A	O
/	O
G	O
)	O
polymorphisms	O
as	O
follows	O
:	O
COL4A3	O
(	O
G	O
/	O
T	O
)	O
;	O
TT	O
vs.	O
GG	O
,	O
odds	O
ratio	O
(	O
OR	O
)	O
=0.235	O
,	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
)	O
=0.063-0.0802	O
(	O
P=0.013	O
)	O
and	O
T	O
vs.	O
G	O
,	O
OR	O
=0.592	O
,	O
95	O
%	O
CI	O
=0.371-0.943	O
(	O
P=0.026	O
)	O
;	O
Matrix	O
metallopeptidase	I:C1334523
9	I:C1334523
(	O
A	B:C0001407
/	O
G	O
)	O
;	O
A	O
G	O
vs.	O
GG	O
,	O
OR	O
=	O
2.429	O
,	O
95	O
%	O
CI	O
=	O
1.232-4.820	O
(	O
P=0.008	O
)	O
and	O
A	O
vs.	O
G	O
,	O
OR	O
=	O
2.176	O
,	O
95	O
%	O
CI	O
=	O
1.155-4.130	O
(	O
P=0.013	O
)	O
.	O

The	O
findings	O
demonstrated	O
significant	O
differences	O
between	O
genotypic	O
and	O
allelic	O
distributions	O
of	O
COL4A3	O
(	O
G	O
/	O
T	O
)	O
and	O
Matrix	O
metallopeptidase	I:C1334523
9	I:C1334523
(	O
A	O
/	O
G	O
)	O
polymorphisms	O
as	O
follows	O
:	O
COL4A3	O
(	O
G	O
/	O
T	O
)	O
;	O
TT	O
vs.	O
GG	O
,	O
odds	O
ratio	O
(	O
OR	O
)	O
=0.235	O
,	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
)	O
=0.063-0.0802	O
(	O
P=0.013	O
)	O
and	O
T	O
vs.	O
G	O
,	O
OR	O
=0.592	O
,	O
95	O
%	O
CI	O
=0.371-0.943	O
(	O
P=0.026	O
)	O
;	O
Matrix	O
metallopeptidase	I:C1334523
9	I:C1334523
(	O
A	O
/	O
G	B:C0018321
)	O
;	O
A	O
G	O
vs.	O
GG	O
,	O
OR	O
=	O
2.429	O
,	O
95	O
%	O
CI	O
=	O
1.232-4.820	O
(	O
P=0.008	O
)	O
and	O
A	O
vs.	O
G	O
,	O
OR	O
=	O
2.176	O
,	O
95	O
%	O
CI	O
=	O
1.155-4.130	O
(	O
P=0.013	O
)	O
.	O

The	O
findings	O
demonstrated	O
significant	O
differences	O
between	O
genotypic	O
and	O
allelic	O
distributions	O
of	O
COL4A3	O
(	O
G	O
/	O
T	O
)	O
and	O
Matrix	O
metallopeptidase	I:C1334523
9	I:C1334523
(	O
A	O
/	O
G	O
)	O
polymorphisms	O
as	O
follows	O
:	O
COL4A3	O
(	O
G	O
/	O
T	O
)	O
;	O
TT	O
vs.	O
GG	O
,	O
odds	O
ratio	O
(	O
OR	O
)	O
=0.235	O
,	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
)	O
=0.063-0.0802	O
(	O
P=0.013	O
)	O
and	O
T	O
vs.	O
G	O
,	O
OR	O
=0.592	O
,	O
95	O
%	O
CI	O
=0.371-0.943	O
(	O
P=0.026	O
)	O
;	O
Matrix	O
metallopeptidase	I:C1334523
9	I:C1334523
(	O
A	O
/	O
G	O
)	O
;	O
A	B:C0001407
G	O
vs.	O
GG	O
,	O
OR	O
=	O
2.429	O
,	O
95	O
%	O
CI	O
=	O
1.232-4.820	O
(	O
P=0.008	O
)	O
and	O
A	O
vs.	O
G	O
,	O
OR	O
=	O
2.176	O
,	O
95	O
%	O
CI	O
=	O
1.155-4.130	O
(	O
P=0.013	O
)	O
.	O

The	O
findings	O
demonstrated	O
significant	O
differences	O
between	O
genotypic	O
and	O
allelic	O
distributions	O
of	O
COL4A3	O
(	O
G	O
/	O
T	O
)	O
and	O
Matrix	O
metallopeptidase	I:C1334523
9	I:C1334523
(	O
A	O
/	O
G	O
)	O
polymorphisms	O
as	O
follows	O
:	O
COL4A3	O
(	O
G	O
/	O
T	O
)	O
;	O
TT	O
vs.	O
GG	O
,	O
odds	O
ratio	O
(	O
OR	O
)	O
=0.235	O
,	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
)	O
=0.063-0.0802	O
(	O
P=0.013	O
)	O
and	O
T	O
vs.	O
G	O
,	O
OR	O
=0.592	O
,	O
95	O
%	O
CI	O
=0.371-0.943	O
(	O
P=0.026	O
)	O
;	O
Matrix	O
metallopeptidase	I:C1334523
9	I:C1334523
(	O
A	O
/	O
G	O
)	O
;	O
A	O
G	B:C0018321
vs.	O
GG	O
,	O
OR	O
=	O
2.429	O
,	O
95	O
%	O
CI	O
=	O
1.232-4.820	O
(	O
P=0.008	O
)	O
and	O
A	O
vs.	O
G	O
,	O
OR	O
=	O
2.176	O
,	O
95	O
%	O
CI	O
=	O
1.155-4.130	O
(	O
P=0.013	O
)	O
.	O

The	O
findings	O
demonstrated	O
significant	O
differences	O
between	O
genotypic	O
and	O
allelic	O
distributions	O
of	O
COL4A3	O
(	O
G	O
/	O
T	O
)	O
and	O
Matrix	O
metallopeptidase	I:C1334523
9	I:C1334523
(	O
A	O
/	O
G	O
)	O
polymorphisms	O
as	O
follows	O
:	O
COL4A3	O
(	O
G	O
/	O
T	O
)	O
;	O
TT	O
vs.	O
GG	O
,	O
odds	O
ratio	O
(	O
OR	O
)	O
=0.235	O
,	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
)	O
=0.063-0.0802	O
(	O
P=0.013	O
)	O
and	O
T	O
vs.	O
G	O
,	O
OR	O
=0.592	O
,	O
95	O
%	O
CI	O
=0.371-0.943	O
(	O
P=0.026	O
)	O
;	O
Matrix	O
metallopeptidase	I:C1334523
9	I:C1334523
(	O
A	O
/	O
G	O
)	O
;	O
A	O
G	O
vs.	O
GG	B:C0018321
,	O
OR	O
=	O
2.429	O
,	O
95	O
%	O
CI	O
=	O
1.232-4.820	O
(	O
P=0.008	O
)	O
and	O
A	O
vs.	O
G	O
,	O
OR	O
=	O
2.176	O
,	O
95	O
%	O
CI	O
=	O
1.155-4.130	O
(	O
P=0.013	O
)	O
.	O

The	O
findings	O
demonstrated	O
significant	O
differences	O
between	O
genotypic	O
and	O
allelic	O
distributions	O
of	O
COL4A3	O
(	O
G	O
/	O
T	O
)	O
and	O
Matrix	O
metallopeptidase	I:C1334523
9	I:C1334523
(	O
A	O
/	O
G	O
)	O
polymorphisms	O
as	O
follows	O
:	O
COL4A3	O
(	O
G	O
/	O
T	O
)	O
;	O
TT	O
vs.	O
GG	O
,	O
odds	O
ratio	O
(	O
OR	O
)	O
=0.235	O
,	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
)	O
=0.063-0.0802	O
(	O
P=0.013	O
)	O
and	O
T	O
vs.	O
G	O
,	O
OR	O
=0.592	O
,	O
95	O
%	O
CI	O
=0.371-0.943	O
(	O
P=0.026	O
)	O
;	O
Matrix	O
metallopeptidase	I:C1334523
9	I:C1334523
(	O
A	O
/	O
G	O
)	O
;	O
A	O
G	O
vs.	O
GG	O
,	O
OR	O
=	O
2.429	O
,	O
95	O
%	O
CI	O
=	O
1.232-4.820	O
(	O
P=0.008	O
)	O
and	O
A	B:C0001407
vs.	O
G	O
,	O
OR	O
=	O
2.176	O
,	O
95	O
%	O
CI	O
=	O
1.155-4.130	O
(	O
P=0.013	O
)	O
.	O

The	O
findings	O
demonstrated	O
significant	O
differences	O
between	O
genotypic	O
and	O
allelic	O
distributions	O
of	O
COL4A3	O
(	O
G	O
/	O
T	O
)	O
and	O
Matrix	O
metallopeptidase	I:C1334523
9	I:C1334523
(	O
A	O
/	O
G	O
)	O
polymorphisms	O
as	O
follows	O
:	O
COL4A3	O
(	O
G	O
/	O
T	O
)	O
;	O
TT	O
vs.	O
GG	O
,	O
odds	O
ratio	O
(	O
OR	O
)	O
=0.235	O
,	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
)	O
=0.063-0.0802	O
(	O
P=0.013	O
)	O
and	O
T	O
vs.	O
G	O
,	O
OR	O
=0.592	O
,	O
95	O
%	O
CI	O
=0.371-0.943	O
(	O
P=0.026	O
)	O
;	O
Matrix	O
metallopeptidase	I:C1334523
9	I:C1334523
(	O
A	O
/	O
G	O
)	O
;	O
A	O
G	O
vs.	O
GG	O
,	O
OR	O
=	O
2.429	O
,	O
95	O
%	O
CI	O
=	O
1.232-4.820	O
(	O
P=0.008	O
)	O
and	O
A	O
vs.	O
G	B:C0018321
,	O
OR	O
=	O
2.176	O
,	O
95	O
%	O
CI	O
=	O
1.155-4.130	O
(	O
P=0.013	O
)	O
.	O

No	O
significant	O
association	O
was	O
identified	O
between	O
TIMP	B:C1367459
metallopeptidase	I:C1367459
inhibitor	I:C1367459
1	I:C1367459
(	O
A	O
/	O
G	O
)	O
polymorphism	O
and	O
Type	O
2	I:C0011860
diabetes	I:C0011860
in	O
females	O
and	O
males	O
.	O

No	O
significant	O
association	O
was	O
identified	O
between	O
TIMP	O
metallopeptidase	I:C1367459
inhibitor	I:C1367459
1	I:C1367459
(	O
A	B:C0001407
/	O
G	O
)	O
polymorphism	O
and	O
Type	O
2	I:C0011860
diabetes	I:C0011860
in	O
females	O
and	O
males	O
.	O

No	O
significant	O
association	O
was	O
identified	O
between	O
TIMP	O
metallopeptidase	I:C1367459
inhibitor	I:C1367459
1	I:C1367459
(	O
A	O
/	O
G	B:C0018321
)	O
polymorphism	O
and	O
Type	O
2	I:C0011860
diabetes	I:C0011860
in	O
females	O
and	O
males	O
.	O

No	O
significant	O
association	O
was	O
identified	O
between	O
TIMP	O
metallopeptidase	I:C1367459
inhibitor	I:C1367459
1	I:C1367459
(	O
A	O
/	O
G	O
)	O
polymorphism	O
and	O
Type	B:C0011860
2	I:C0011860
diabetes	I:C0011860
in	O
females	O
and	O
males	O
.	O

No	O
significant	O
association	O
was	O
identified	O
between	O
TIMP	O
metallopeptidase	I:C1367459
inhibitor	I:C1367459
1	I:C1367459
(	O
A	O
/	O
G	O
)	O
polymorphism	O
and	O
Type	O
2	I:C0011860
diabetes	I:C0011860
in	O
females	B:C0043210
and	O
males	O
.	O

No	O
significant	O
association	O
was	O
identified	O
between	O
TIMP	O
metallopeptidase	I:C1367459
inhibitor	I:C1367459
1	I:C1367459
(	O
A	O
/	O
G	O
)	O
polymorphism	O
and	O
Type	O
2	I:C0011860
diabetes	I:C0011860
in	O
females	O
and	O
males	B:C0025266
.	O

Thus	O
,	O
the	O
genotypic	O
and	O
allelic	B:C0002085
distributions	O
of	O
COL4A3	O
(	O
G	O
/	O
T	O
)	O
and	O
Matrix	O
metallopeptidase	I:C1334523
9	I:C1334523
(	O
A	O
/	O
G	O
)	O
polymorphisms	O
were	O
associated	O
with	O
Type	O
2	I:C0011860
diabetes	I:C0011860
.	O

Thus	O
,	O
the	O
genotypic	O
and	O
allelic	O
distributions	O
of	O
COL4A3	B:C1332774
(	O
G	O
/	O
T	O
)	O
and	O
Matrix	O
metallopeptidase	I:C1334523
9	I:C1334523
(	O
A	O
/	O
G	O
)	O
polymorphisms	O
were	O
associated	O
with	O
Type	O
2	I:C0011860
diabetes	I:C0011860
.	O

Thus	O
,	O
the	O
genotypic	O
and	O
allelic	O
distributions	O
of	O
COL4A3	O
(	O
G	B:C0018321
/	O
T	O
)	O
and	O
Matrix	O
metallopeptidase	I:C1334523
9	I:C1334523
(	O
A	O
/	O
G	O
)	O
polymorphisms	O
were	O
associated	O
with	O
Type	O
2	I:C0011860
diabetes	I:C0011860
.	O

Thus	O
,	O
the	O
genotypic	O
and	O
allelic	O
distributions	O
of	O
COL4A3	O
(	O
G	O
/	O
T	B:C0040087
)	O
and	O
Matrix	O
metallopeptidase	I:C1334523
9	I:C1334523
(	O
A	O
/	O
G	O
)	O
polymorphisms	O
were	O
associated	O
with	O
Type	O
2	I:C0011860
diabetes	I:C0011860
.	O

Thus	O
,	O
the	O
genotypic	O
and	O
allelic	O
distributions	O
of	O
COL4A3	O
(	O
G	O
/	O
T	O
)	O
and	O
Matrix	B:C1334523
metallopeptidase	I:C1334523
9	I:C1334523
(	O
A	O
/	O
G	O
)	O
polymorphisms	O
were	O
associated	O
with	O
Type	O
2	I:C0011860
diabetes	I:C0011860
.	O

Thus	O
,	O
the	O
genotypic	O
and	O
allelic	O
distributions	O
of	O
COL4A3	O
(	O
G	O
/	O
T	O
)	O
and	O
Matrix	O
metallopeptidase	I:C1334523
9	I:C1334523
(	O
A	B:C0001407
/	O
G	O
)	O
polymorphisms	O
were	O
associated	O
with	O
Type	O
2	I:C0011860
diabetes	I:C0011860
.	O

Thus	O
,	O
the	O
genotypic	O
and	O
allelic	O
distributions	O
of	O
COL4A3	O
(	O
G	O
/	O
T	O
)	O
and	O
Matrix	O
metallopeptidase	I:C1334523
9	I:C1334523
(	O
A	O
/	O
G	B:C0018321
)	O
polymorphisms	O
were	O
associated	O
with	O
Type	O
2	I:C0011860
diabetes	I:C0011860
.	O

Thus	O
,	O
the	O
genotypic	O
and	O
allelic	O
distributions	O
of	O
COL4A3	O
(	O
G	O
/	O
T	O
)	O
and	O
Matrix	O
metallopeptidase	I:C1334523
9	I:C1334523
(	O
A	O
/	O
G	O
)	O
polymorphisms	O
were	O
associated	O
with	O
Type	B:C0011860
2	I:C0011860
diabetes	I:C0011860
.	O

In	O
addition	O
,	O
no	O
significant	O
association	O
was	O
identified	O
in	O
the	O
genotypic	O
distribution	O
of	O
the	O
TIMP	B:C1367459
metallopeptidase	I:C1367459
inhibitor	I:C1367459
1	I:C1367459
(	O
A	O
/	O
G	O
)	O
gene	O
in	O
females	O
and	O
in	O
males	O
.	O

In	O
addition	O
,	O
no	O
significant	O
association	O
was	O
identified	O
in	O
the	O
genotypic	O
distribution	O
of	O
the	O
TIMP	O
metallopeptidase	I:C1367459
inhibitor	I:C1367459
1	I:C1367459
(	O
A	B:C0001407
/	O
G	O
)	O
gene	O
in	O
females	O
and	O
in	O
males	O
.	O

In	O
addition	O
,	O
no	O
significant	O
association	O
was	O
identified	O
in	O
the	O
genotypic	O
distribution	O
of	O
the	O
TIMP	O
metallopeptidase	I:C1367459
inhibitor	I:C1367459
1	I:C1367459
(	O
A	O
/	O
G	B:C0018321
)	O
gene	O
in	O
females	O
and	O
in	O
males	O
.	O

In	O
addition	O
,	O
no	O
significant	O
association	O
was	O
identified	O
in	O
the	O
genotypic	O
distribution	O
of	O
the	O
TIMP	O
metallopeptidase	I:C1367459
inhibitor	I:C1367459
1	I:C1367459
(	O
A	O
/	O
G	O
)	O
gene	B:C0017337
in	O
females	O
and	O
in	O
males	O
.	O

In	O
addition	O
,	O
no	O
significant	O
association	O
was	O
identified	O
in	O
the	O
genotypic	O
distribution	O
of	O
the	O
TIMP	O
metallopeptidase	I:C1367459
inhibitor	I:C1367459
1	I:C1367459
(	O
A	O
/	O
G	O
)	O
gene	O
in	O
females	B:C0043210
and	O
in	O
males	O
.	O

In	O
addition	O
,	O
no	O
significant	O
association	O
was	O
identified	O
in	O
the	O
genotypic	O
distribution	O
of	O
the	O
TIMP	O
metallopeptidase	I:C1367459
inhibitor	I:C1367459
1	I:C1367459
(	O
A	O
/	O
G	O
)	O
gene	O
in	O
females	O
and	O
in	O
males	B:C0025266
.	O

Further	O
studies	O
in	O
other	O
ethnic	B:C0015031
groups	I:C0015031
are	O
required	O
to	O
confirm	O
these	O
findings	O
.	O

